These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 36253467)

  • 1. A scalable platform to discover antimicrobials of ribosomal origin.
    Ayikpoe RS; Shi C; Battiste AJ; Eslami SM; Ramesh S; Simon MA; Bothwell IR; Lee H; Rice AJ; Ren H; Tian Q; Harris LA; Sarksian R; Zhu L; Frerk AM; Precord TW; van der Donk WA; Mitchell DA; Zhao H
    Nat Commun; 2022 Oct; 13(1):6135. PubMed ID: 36253467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-free biosynthesis and engineering of ribosomally synthesized lanthipeptides.
    Liu WQ; Ji X; Ba F; Zhang Y; Xu H; Huang S; Zheng X; Liu Y; Ling S; Jewett MC; Li J
    Nat Commun; 2024 May; 15(1):4336. PubMed ID: 38773100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The genomic landscape of ribosomal peptides containing thiazole and oxazole heterocycles.
    Cox CL; Doroghazi JR; Mitchell DA
    BMC Genomics; 2015 Oct; 16():778. PubMed ID: 26462797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome mining for ribosomally synthesized and post-translationally modified peptides (RiPPs) in anaerobic bacteria.
    Letzel AC; Pidot SJ; Hertweck C
    BMC Genomics; 2014 Nov; 15(1):983. PubMed ID: 25407095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nocathioamides, Uncovered by a Tunable Metabologenomic Approach, Define a Novel Class of Chimeric Lanthipeptides.
    Saad H; Aziz S; Gehringer M; Kramer M; Straetener J; Berscheid A; Brötz-Oesterhelt H; Gross H
    Angew Chem Int Ed Engl; 2021 Jul; 60(30):16472-16479. PubMed ID: 33991039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expansion of RiPP biosynthetic space through integration of pan-genomics and machine learning uncovers a novel class of lanthipeptides.
    Kloosterman AM; Cimermancic P; Elsayed SS; Du C; Hadjithomas M; Donia MS; Fischbach MA; van Wezel GP; Medema MH
    PLoS Biol; 2020 Dec; 18(12):e3001026. PubMed ID: 33351797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RiPP antibiotics: biosynthesis and engineering potential.
    Hudson GA; Mitchell DA
    Curr Opin Microbiol; 2018 Oct; 45():61-69. PubMed ID: 29533845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of chemical synthesis in developing RiPP antibiotics.
    Rowe SM; Spring DR
    Chem Soc Rev; 2021 Apr; 50(7):4245-4258. PubMed ID: 33635302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mammalian Commensal
    He Y; Fan A; Han M; Li H; Li M; Fan H; An X; Song L; Zhu S; Tong Y
    Biochemistry; 2023 Jan; 62(2):462-475. PubMed ID: 36577516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advancements in the Application of Ribosomally Synthesized and Post-Translationally Modified Peptides (RiPPs).
    Han SW; Won HS
    Biomolecules; 2024 Apr; 14(4):. PubMed ID: 38672495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery and Characterization of a Class IV Lanthipeptide with a Nonoverlapping Ring Pattern.
    Ren H; Shi C; Bothwell IR; van der Donk WA; Zhao H
    ACS Chem Biol; 2020 Jun; 15(6):1642-1649. PubMed ID: 32356655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Precursor peptide-targeted mining of more than one hundred thousand genomes expands the lanthipeptide natural product family.
    Walker MC; Eslami SM; Hetrick KJ; Ackenhusen SE; Mitchell DA; van der Donk WA
    BMC Genomics; 2020 Jun; 21(1):387. PubMed ID: 32493223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineering lanthipeptides by introducing a large variety of RiPP modifications to obtain new-to-nature bioactive peptides.
    Fu Y; Xu Y; Ruijne F; Kuipers OP
    FEMS Microbiol Rev; 2023 May; 47(3):. PubMed ID: 37096385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure of ribosome-bound azole-modified peptide phazolicin rationalizes its species-specific mode of bacterial translation inhibition.
    Travin DY; Watson ZL; Metelev M; Ward FR; Osterman IA; Khven IM; Khabibullina NF; Serebryakova M; Mergaert P; Polikanov YS; Cate JHD; Severinov K
    Nat Commun; 2019 Oct; 10(1):4563. PubMed ID: 31594941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid Discovery of Glycocins through Pathway Refactoring in Escherichia coli.
    Ren H; Biswas S; Ho S; van der Donk WA; Zhao H
    ACS Chem Biol; 2018 Oct; 13(10):2966-2972. PubMed ID: 30183259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Out for a RiPP: challenges and advances in genome mining of ribosomal peptides from fungi.
    Kessler SC; Chooi YH
    Nat Prod Rep; 2022 Feb; 39(2):222-230. PubMed ID: 34581394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the roles of ribosomal peptides in prokaryote-phage interactions through deep learning-enabled metagenome mining.
    Gao Y; Zhong Z; Zhang D; Zhang J; Li YX
    Microbiome; 2024 May; 12(1):94. PubMed ID: 38790030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mimicry of a Non-ribosomally Produced Antimicrobial, Brevicidine, by Ribosomal Synthesis and Post-translational Modification.
    Zhao X; Li Z; Kuipers OP
    Cell Chem Biol; 2020 Oct; 27(10):1262-1271.e4. PubMed ID: 32707039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of protein-protein interactions in the biosynthesis of ribosomally synthesized and post-translationally modified peptides.
    Sikandar A; Koehnke J
    Nat Prod Rep; 2019 Nov; 36(11):1576-1588. PubMed ID: 30920567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of the mCherry fluorescent protein to optimize the expression of class I lanthipeptides in Escherichia coli.
    Van Zyl WF; Van Staden AD; Dicks LMT; Trindade M
    Microb Cell Fact; 2023 Aug; 22(1):149. PubMed ID: 37559122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.